Ulotaront (SEP363856) Reduces Dopamine Release and Synthesis Capacity in Mice and Patients With Schizophrenia

Biological Psychiatry · Published 2026-06-24 · DOI 10.1016/j.biopsych.2026.05.007

Authors (1)

Per Svenningsson

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Svenningsson, P. (2026). Ulotaront (SEP363856) Reduces Dopamine Release and Synthesis Capacity in Mice and Patients With Schizophrenia. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2026.05.007

Related articles